English

ALLARITY THERAPEUTICS, INC.

EDGAR

ALLR Current report (8-K) · filed 2026-10-30

37 filing records in this dataset, filed from 2021-08-20 to 2026-10-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

120 thousand USD

2019 · USD

Exact inputs and evidence

Revenue: 120000 USD Source

Operating margin

-14,675.83%

2019 · %

Exact inputs and evidence

Operating Income: -17611000 USD Source
Revenue: 120000 USD Source

Operating cash flow

-10.1 million USD

2019 · USD

Exact inputs and evidence

Operating Cash Flow: -10113000 USD Source

Free cash flow

-10.1 million USD

2019 · USD

Exact inputs and evidence

Operating Cash Flow: -10113000 USD Source
Capital Expenditure: 8000 USD Source

Cash and cash equivalents: 17 million USD 2026-06-30 Source
Exact value

16982000 USD
Long-term debt including current maturities: 2.69 million USD 2023-12-31 Source
Exact value

2687000 USD
Shares outstanding: 15.9 million shares 2026-06-30 Source
Exact value

15910724 shares

Reported share-count change

8.83% · 1.29 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

14619636 shares · 2025-06-30· Source
15910724 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-12.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -2806000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -11231000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -7858000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -2750000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -3405000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-13.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -11600000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -8167000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -14820000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -11600000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -4500000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -7100000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -4500000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2019-12-31
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2023-12-31
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 13.28 million

Prior period

−USD 24.52 million

2024-01-01 – 2024-12-31
Current period

−USD 11.23 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-11231000 − -24515000 = 13284000 USD

-24515000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-11231000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Year-over-year change in Net income: 13284000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -11231000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1699531 Filing: 000143774926010310 Input fundies:NetIncome: -24515000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1700215 Filing: 000143774926010310
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.53 million

Prior period

−USD 17.35 million

2024-01-01 – 2024-12-31
Current period

−USD 14.82 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-14820000 − -17352000 = 2532000 USD

-17352000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-14820000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Year-over-year change in Operating cash flow: 2532000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14820000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1729479 Filing: 000143774926010310 Input fundies:OperatingCashFlow: -17352000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1730278 Filing: 000143774926010310
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-97.3%

Prior period

USD 298,000

2024-01-01 – 2024-12-31
Current period

USD 8,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

8000 − 298000 = -290000 USD

298000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
8000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Year-over-year change in Capital expenditure: -290000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1732537 Filing: 000143774926010310 Input fundies:CapitalExpenditure: 298000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1733322 Filing: 000143774926010310
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 120,000 100% of revenue
Operating costs Derived USD 17.73 million 14,776% of revenue
Operating income −USD 17.61 million −14,676% of revenue
Tax, interest and other Derived −USD 3.21 million −2,676% of revenue
Net income −USD 14.4 million −12,000% of revenue

Cash

Operating cash flow −USD 10.11 million −8,428% of revenue
Capital expenditure USD 8,000 6.7% of revenue
Free cash flow Derived −USD 10.12 million −8,434% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 14,776% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	120000	17731000 Derived	-17611000	-3211000 Derived	-14400000	-10121000 Derived	Source 2019-01-01 – 2019-12-31: 120000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -17611000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -14400000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -10113000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 8000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 120K 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	120000	Revenue: 120000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 120000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -14,675.8% 2019

Net margin -12,000% 2019

Free cash flow margin -8,434.2% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-14,675.8%	Operating Income: -17611000 Open source Revenue: 120000 Open source
20192019-12-31	Net margin	-12,000%	Net Income: -14400000 Open source Revenue: 120000 Open source
20192019-12-31	Free cash flow margin	-8,434.2%	Revenue: 120000 Open source Operating Cash Flow: -10113000 Open source Capital Expenditure: 8000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.1M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-10113000	Operating Cash Flow: -10113000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.1M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-10121000	Operating Cash Flow: -10113000 Open source Capital Expenditure: 8000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.9% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	33.9%	Total Liabilities: 10704000 Open source Total Assets: 31607000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.71× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	0.71×	Current Assets: 3343000 Open source Current Liabilities: 4719000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 14.4 million Exact value Exact value: -14400000 USD 2019-01-01 – 2019-12-31: -14400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2019-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -14400000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14400000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390021047633/fs12021_allarity.htm#6936228 Filing: 000121390021047633 The citation records this snapshot. The page link may show a newer release later.	−USD 10.11 million Exact value Exact value: -10113000 USD 2019-01-01 – 2019-12-31: -10113000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2019-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -10113000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10113000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390021047633/fs12021_allarity.htm#7042346 Filing: 000121390021047633 The citation records this snapshot. The page link may show a newer release later.	USD 8,000 Exact value Exact value: 8000 USD 2019-01-01 – 2019-12-31: 8000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2019-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: 8000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390021047633/fs12021_allarity.htm#7055051 Filing: 000121390021047633 The citation records this snapshot. The page link may show a newer release later.	−USD 10.12 million Calculation and evidence -10113000 − 8000 USD Exact free cash flow: -10121000 USD 2019-01-01 – 2019-12-31: -10113000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 8000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2019-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -10121000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10113000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390021047633/fs12021_allarity.htm#7042346 Filing: 000121390021047633 Input fundies:CapitalExpenditure: 8000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390021047633/fs12021_allarity.htm#7055051 Filing: 000121390021047633 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 6.62 million Exact value Exact value: -6617000 USD 2020-01-01 – 2020-12-31: -6617000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2020-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -6617000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6617000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390022027311/f10k2021_allaritytherap.htm#2501720 Filing: 000121390022027311 The citation records this snapshot. The page link may show a newer release later.	−USD 7.25 million Exact value Exact value: -7251000 USD 2020-01-01 – 2020-12-31: -7251000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2020-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -7251000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7251000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390022027311/f10k2021_allaritytherap.htm#2518551 Filing: 000121390022027311 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2020-01-01 – 2020-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2020-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390022027311/f10k2021_allaritytherap.htm#2519684 Filing: 000121390022027311 The citation records this snapshot. The page link may show a newer release later.	−USD 7.25 million Calculation and evidence -7251000 − 3000 USD Exact free cash flow: -7254000 USD 2020-01-01 – 2020-12-31: -7251000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2020-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -7254000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7251000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390022027311/f10k2021_allaritytherap.htm#2518551 Filing: 000121390022027311 Input fundies:CapitalExpenditure: 3000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390022027311/f10k2021_allaritytherap.htm#2519684 Filing: 000121390022027311 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 26.65 million Exact value Exact value: -26648000 USD 2021-01-01 – 2021-12-31: -26648000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2021-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -26648000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26648000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390023019295/f10k2022_allaritytherap.htm#2554293 Filing: 000121390023019295 The citation records this snapshot. The page link may show a newer release later.	−USD 14.89 million Exact value Exact value: -14886000 USD 2021-01-01 – 2021-12-31: -14886000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2021-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -14886000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14886000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390023019295/f10k2022_allaritytherap.htm#2569998 Filing: 000121390023019295 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 16.06 million Exact value Exact value: -16058000 USD 2022-01-01 – 2022-12-31: -16058000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2022-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -16058000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16058000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm#2332301 Filing: 000121390024020864 The citation records this snapshot. The page link may show a newer release later.	−USD 16.82 million Exact value Exact value: -16817000 USD 2022-01-01 – 2022-12-31: -16817000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2022-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -16817000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16817000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm#2361234 Filing: 000121390024020864 The citation records this snapshot. The page link may show a newer release later.	USD 18,000 Exact value Exact value: 18000 USD 2022-01-01 – 2022-12-31: 18000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2022-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: 18000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm#2364980 Filing: 000121390024020864 The citation records this snapshot. The page link may show a newer release later.	−USD 16.84 million Calculation and evidence -16817000 − 18000 USD Exact free cash flow: -16835000 USD 2022-01-01 – 2022-12-31: -16817000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 18000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2022-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -16835000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16817000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm#2361234 Filing: 000121390024020864 Input fundies:CapitalExpenditure: 18000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm#2364980 Filing: 000121390024020864 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 11.9 million Exact value Exact value: -11901000 USD 2023-01-01 – 2023-12-31: -11901000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2023-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -11901000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11901000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm#2026099 Filing: 000143774925010198 The citation records this snapshot. The page link may show a newer release later.	−USD 12.75 million Exact value Exact value: -12745000 USD 2023-01-01 – 2023-12-31: -12745000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2023-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -12745000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12745000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm#2064847 Filing: 000143774925010198 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: -0 USD 2023-01-01 – 2023-12-31: -0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2023-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: -0 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: -0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm#2068042 Filing: 000143774925010198 The citation records this snapshot. The page link may show a newer release later.	−USD 12.75 million Calculation and evidence -12745000 − -0 USD Exact free cash flow: -12745000 USD 2023-01-01 – 2023-12-31: -12745000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: -0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2023-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -12745000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12745000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm#2064847 Filing: 000143774925010198 Input fundies:CapitalExpenditure: -0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm#2068042 Filing: 000143774925010198 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 24.52 million Exact value Exact value: -24515000 USD 2024-01-01 – 2024-12-31: -24515000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2024-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -24515000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24515000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1700215 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	−USD 17.35 million Exact value Exact value: -17352000 USD 2024-01-01 – 2024-12-31: -17352000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2024-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -17352000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17352000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1730278 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	USD 298,000 Exact value Exact value: 298000 USD 2024-01-01 – 2024-12-31: 298000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2024-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: 298000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 298000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1733322 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	−USD 17.65 million Calculation and evidence -17352000 − 298000 USD Exact free cash flow: -17650000 USD 2024-01-01 – 2024-12-31: -17352000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 298000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2024-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -17650000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17352000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1730278 Filing: 000143774926010310 Input fundies:CapitalExpenditure: 298000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1733322 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 11.23 million Exact value Exact value: -11231000 USD 2025-01-01 – 2025-12-31: -11231000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Net Income: -11231000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11231000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1699531 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	−USD 14.82 million Exact value Exact value: -14820000 USD 2025-01-01 – 2025-12-31: -14820000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Operating Cash Flow: -14820000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14820000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1729479 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	USD 8,000 Exact value Exact value: 8000 USD 2025-01-01 – 2025-12-31: 8000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Capital Expenditure: 8000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1732537 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.	−USD 14.83 million Calculation and evidence -14820000 − 8000 USD Exact free cash flow: -14828000 USD 2025-01-01 – 2025-12-31: -14820000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 8000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLARITY THERAPEUTICS, INC. · 2025-12-31 ALLARITY THERAPEUTICS, INC. (edgar:1860657) Free cash flow: -14828000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:42:25Z Snapshot: 6fdf8f8346ce1d47f5075c955ca34bac565b3499cec5afa92b4e0c8a5d659ac7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1860657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14820000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1729479 Filing: 000143774926010310 Input fundies:CapitalExpenditure: 8000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm#1732537 Filing: 000143774926010310 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 1,417 latest values · 1,417 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001860657, 1860657, ALLR, edgar:1860657

Also known as ALLARITY THERAPEUTICS, INC., Allarity Therapeutics, Inc.

ALLARITY THERAPEUTICS, INC.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation